In the Wake of Failed Alzheimer's Drug Trials, Scientists Are Cautiously Finding Hope With a New Strategy

The field of Alzheimer’s research one filled with disappointment. Just last week, yet another drug failed its Phase 3 clinical trial, continuing the 15-year-long losing streak since a truly new Alzheimer’s treatment was approved by the Food and Drug Administration.

Read more…

No Responses to “In the Wake of Failed Alzheimer's Drug Trials, Scientists Are Cautiously Finding Hope With a New Strategy”

Post a Comment